What is it about?
A very short editorial suggesting how the whole company / academia / foundation /government drug discovery ecosystem could share molecules, models and data while at the same time retaining IP and selectively sharing others.
Featured Image
Why is it important?
Drug discovery is expensive, takes years and so any methods to try to speed it up or lower costs could be impactful. More collaboration and sharing could be an alternative and software can facilitate this.
Perspectives
A very simple idea which built on the many technologies, databases and tools being developed at the time. I still don't think we have reached close to what is possible.
Dr Sean Ekins
Collaborations in Chemistry
Read the Original
This page is a summary of: Alternative business models for drug discovery, Drug Discovery Today, August 2011, Elsevier,
DOI: 10.1016/j.drudis.2011.06.012.
You can read the full text:
Contributors
The following have contributed to this page
